The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease

Cardiorenal Medicine

Peter A. McCullough¹  Manjula Kurella Tamura¹  Adam Whaley-Connell¹  Andrew Bombeck¹  Shu-Cheng Chen¹  Suying Li¹  for the Kidney Early Evaluation Program Investigators¹  James R. Sowers¹  Samy I. McFarlane¹  Georges Saab¹  Keith Norris¹  George L. Bakris¹ 

[1] $$

关键词: Chronic kidney disease;    Hyperparathyroidism;    KEEP;    Metabolic syndrome;   

DOI  :  10.1159/000327149

来源: S Karger AG

【 摘 要 】

Aims: The relationship between parathyroid hormone (PTH) and the cardiorenal metabolic syndrome was examined among non-diabetic persons with chronic kidney disease (CKD). Methods: In a cross-sectional analysis, the relationship between PTH levels and the cardiorenal metabolic syndrome was investigated in 3,215 non-diabetic participants in the National Kidney Foundation-Kidney Early Evaluation Program (KEEP 2.0) found to have CKD (eGFR <60 ml/min/1.73 m²). Results: In unadjusted analyses, the prevalence of the cardiorenal metabolic syndrome increased along increasing PTH quartiles (31.7, 33.8, 37.3, and 48.7%, respectively, p for trend <0.0001). After multivariate adjustment, as compared to the first PTH quartile, odds of the cardiorenal metabolic syndrome were 16% (p = 0.18), 35% (p = 0.006), and 80% (p < 0.0001) higher for the second, third, and fourth quartiles, respectively. When taken as a continuous predictor, each standard deviation increase of natural log transformed PTH was associated with 26% (p < 0.0001) higher odds of the cardiorenal metabolic syndrome. The association of PTH with the cardiorenal metabolic syndrome was not modified by age or gender (p for interaction was not significant for both modifiers). Conclusions: Among an outpatient non-diabetic population with CKD, higher PTH levels were associated with a higher prevalence of the cardiorenal metabolic syndrome.

【 授权许可】

Unknown